Novo Nordisk (DE:NOV)
XETRA:NOV
Holding DE:NOV?
Track your performance easily

Novo Nordisk (NOV) Cash flow

181 Followers

Novo Nordisk Cash Flow

DE:NOV's free cash flow for Q4 2023 was kr-6.88B. For the 2023 fiscal year, DE:NOV's free cash flow was decreased by kr5.88B and operating cash flow was kr9.55B. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
kr 97.37Bkr 108.91Bkr 78.89Bkr 55.00Bkr 51.95Bkr 46.78B
Investing Cash Flow
kr -46.28Bkr -43.89Bkr -24.92Bkr -31.61Bkr -22.44Bkr -11.51B
Financing Cash Flow
kr -82.53Bkr -63.16Bkr -51.80Bkr -25.49Bkr -32.24Bkr -35.48B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
kr 42.85Bkr 14.39Bkr 12.65Bkr 10.72Bkr 12.23Bkr 15.41B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
kr -3.24Bkr -1.47Bkr -2.41Bkr 22.16Bkr 4.73Bkr -741.00M
Repayment Of Debt
kr -14.46Bkr -1.47Bkr -13.62Bkr -6.69Bkr -950.00Mkr -822.00M
Free Cash Flow
kr 61.38Bkr 70.01Bkr 64.13Bkr 47.62Bkr 29.88Bkr 35.55B
Domestic Sales
------
Foreign Sales
------
Currency in DKK

Novo Nordisk Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis